These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 522809)

  • 1. [Clinical implication of serum insulin determination. Diagnosis and prognosis in patients with apparent secondary failure of treatment with sulfonylureas (author's transl)].
    Sachse G; Willms B
    Med Klin; 1979 Nov; 74(44):1635-40. PubMed ID: 522809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of diabetes without biguanides. Observation on the course after changing treatment (author's transl)].
    Walter-Sack I; Wolfram G; Zöllner N
    MMW Munch Med Wochenschr; 1979 Aug; 121(35):1109-12. PubMed ID: 114774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and prognostic value of serum insulin determinations after so-called maximal stimulation in life threatening secondary failure of sulfonylurea therapy].
    Sachse G; Willms B
    Verh Dtsch Ges Inn Med; 1978; (84):1195-7. PubMed ID: 741925
    [No Abstract]   [Full Text] [Related]  

  • 4. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
    Willms B
    MMW Munch Med Wochenschr; 1975 Oct; 117(41):1643-8. PubMed ID: 810689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunological determination of insulin in patients with manifest diabetes mellitus as a guide for the planning of therapy (author's transl)].
    Zilker T; Kränzlin T; Schweigart U; Ermler R; Bottermann P
    Med Klin; 1976 Apr; 71(18):761-7. PubMed ID: 818495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic control in 107 maturity onset diabetic out patients (author's transl)].
    Charitanski D; Blouquit Y; Papoz L; Soria J; Rosa J; Tchobroutsky G
    Nouv Presse Med; 1980 Feb; 9(9):585-9. PubMed ID: 6987621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glisoxepide treatment in maturity-onset diabetics (author's transl)].
    Happ J; Beyer J; Ulreich F; Schöffling K; Krause U; Frönlich A
    Dtsch Med Wochenschr; 1976 Nov; 101(45):1643-6. PubMed ID: 1033056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)].
    Haupt E; Laube F; Loy H; Schöffling K
    Med Klin; 1977 Sep; 72(38):1529-36. PubMed ID: 904548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of Glipizide on the blood glucose and insulin in non-ketotic diabetes mellitus (author's transl)].
    Patsch W; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1976 Jan; 88(2):57-9. PubMed ID: 1258487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regadrin treatment of diabetes mellitus].
    Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemic control and treatment patterns in patients with heart failure.
    Tang WH
    Heart Fail Monit; 2006; 5(1):10-4. PubMed ID: 16547530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylurea drugs and insulin-independent diabetes mellitus.
    Lebovitz HE; Feinglos MN
    Compr Ther; 1979 Apr; 5(4):65-71. PubMed ID: 445991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral antidiabetic agents: recent aspects].
    Keller U; Berger W
    Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)].
    Villiger U
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960
    [No Abstract]   [Full Text] [Related]  

  • 18. The rationale for the use of drugs in the treatment of diabetes mellitus.
    Kryston LJ; Shaw RA
    Semin Drug Treat; 1974; 3(4):365-75. PubMed ID: 4207077
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes mellitus under 30 years of age. Results of 18 years experience with oral treatment (author's transl)].
    Mirouze J; Cartry E
    Diabete Metab; 1975 Jun; 1(2):113-8. PubMed ID: 1234068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.